About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Use of Automated Office Blood Pressure Monitoring | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT05395403

Use of Automated Office Blood Pressure Monitoring

Blood pressure measurements by three methods Office Blood Pressure Measurement (OBPM), Automated Office Blood Pressure Measurement (AOBPM), and Home Blood Pressure Measurement (HBPM) were collected re...

Lead sponsor: University of Alabama at Birmingham•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

University of Alabama at Birmingham

Collaborators

Troy University

Age

19 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•19 years and older
•Uncontrolled BP
•Prescribed three or more antihypertensive medications at the time of referral
•Higher risk for poor CV outcomes than patients with essential HTN
•OBPM systolic BP of greater than 140 mmHg and diastolic BP of greater than or equal to 90 mm Hg upon initial clinic assessment.

Exclusion Criteria

•Less than 19 years old
•Had a systolic BP of less than 140 mm Hg and diastolic BP of less than 90 mmHg upon initial clinic assessment.
•Also, patients on less than three antihypertensive medications, with less than three visits, and who have controlled OBPM were excluded.

Related studies

Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women

NCT06647511 · Gestational Hypertension

Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Placement

NCT07439939 · Liver Cirrhosis, Portal Hypertension

RECRUITINGPhase 1/2

Feasibility of Semaglutide in Advanced Lung Disease

NCT05746039 · Obesity, Interstitial Lung Disease, and more

RECRUITINGPhase 3

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

NCT07218029 · Pulmonary Arterial Hypertension

Health Warnings and Counseling for Smoking Cessation

NCT07098065 · Tobacco Cessation, Health Warning Label, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 27, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment28

Start dateMar 2021

Last updatedMay 27, 2022

Condition

Hypertension Uncontrolled Hypertension Hypertension, White Coat Hypertension, Resistant to Conventional Therapy

Locations shown

University of Alabama at Birmingham

Birmingham, Alabama

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 27, 2022Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions